Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 2
1998 3
1999 2
2000 1
2001 7
2003 1
2004 2
2005 5
2006 7
2007 5
2008 3
2009 1
2010 3
2011 4
2012 2
2013 2
2014 3
2015 7
2016 7
2017 8
2018 6
2019 2
2020 4
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 28593989

86 results
Results by year
Filters applied: . Clear all
Page 1
Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge.
Bradley T, Pollara J, Santra S, Vandergrift N, Pittala S, Bailey-Kellogg C, Shen X, Parks R, Goodman D, Eaton A, Balachandran H, Mach LV, Saunders KO, Weiner JA, Scearce R, Sutherland LL, Phogat S, Tartaglia J, Reed SG, Hu SL, Theis JF, Pinter A, Montefiori DC, Kepler TB, Peachman KK, Rao M, Michael NL, Suscovich TJ, Alter G, Ackerman ME, Moody MA, Liao HX, Tomaras G, Ferrari G, Korber BT, Haynes BF. Bradley T, et al. Nat Commun. 2017 Jun 8;8:15711. doi: 10.1038/ncomms15711. Nat Commun. 2017. PMID: 28593989 Free PMC article.
Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques: effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses.
Kumar A, Lifson JD, Silverstein PS, Jia F, Sheffer D, Li Z, Narayan O. Kumar A, et al. Virology. 2000 Aug 15;274(1):149-64. doi: 10.1006/viro.2000.0444. Virology. 2000. PMID: 10936096 Free article.
Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.
Zolla-Pazner S, Powell R, Yahyaei S, Williams C, Jiang X, Li W, Lu S, Wang S, Upadhyay C, Hioe CE, Totrov M, Kong X. Zolla-Pazner S, et al. J Virol. 2016 Nov 28;90(24):10993-11006. doi: 10.1128/JVI.01403-16. Print 2016 Dec 15. J Virol. 2016. PMID: 27630234 Free PMC article.
Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
Someya K, Cecilia D, Ami Y, Nakasone T, Matsuo K, Burda S, Yamamoto H, Yoshino N, Kaizu M, Ando S, Okuda K, Zolla-Pazner S, Yamazaki S, Yamamoto N, Honda M. Someya K, et al. J Virol. 2005 Feb;79(3):1452-62. doi: 10.1128/JVI.79.3.1452-1462.2005. J Virol. 2005. PMID: 15650171 Free PMC article.
Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates.
Saunders KO, Santra S, Parks R, Yates NL, Sutherland LL, Scearce RM, Balachandran H, Bradley T, Goodman D, Eaton A, Stanfield-Oakley SA, Tartaglia J, Phogat S, Pantaleo G, Esteban M, Gomez CE, Perdiguero B, Jacobs B, Kibler K, Korber B, Montefiori DC, Ferrari G, Vandergrift N, Liao HX, Tomaras GD, Haynes BF. Saunders KO, et al. J Virol. 2018 Mar 28;92(8):e02035-17. doi: 10.1128/JVI.02035-17. Print 2018 Apr 15. J Virol. 2018. PMID: 29437967 Free PMC article.
Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model.
Page M, Stebbings R, Berry N, Hull R, Ferguson D, Davis L, Duffy L, Elsley W, Hall J, Ham C, Hassall M, Li B, Mee ET, Quartey-Papafio R, Rose NJ, Mathy N, Voss G, Stott EJ, Almond N. Page M, et al. Retrovirology. 2012 Jul 16;9:56. doi: 10.1186/1742-4690-9-56. Retrovirology. 2012. PMID: 22799593 Free PMC article.
A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infection.
Mooij P, van der Kolk M, Bogers WM, ten Haaft PJ, Van Der Meide P, Almond N, Stott J, Deschamps M, Labbe D, Momin P, Voss G, Von Hoegen P, Bruck C, Heeney JL. Mooij P, et al. AIDS. 1998 Mar 26;12(5):F15-22. doi: 10.1097/00002030-199805000-00002. AIDS. 1998. PMID: 9543435
Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens.
DeVico A, Fouts T, Lewis GK, Gallo RC, Godfrey K, Charurat M, Harris I, Galmin L, Pal R. DeVico A, et al. Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17477-82. doi: 10.1073/pnas.0707399104. Epub 2007 Oct 23. Proc Natl Acad Sci U S A. 2007. PMID: 17956985 Free PMC article.
Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.
Miyake A, Akagi T, Enose Y, Ueno M, Kawamura M, Horiuchi R, Hiraishi K, Adachi M, Serizawa T, Narayan O, Akashi M, Baba M, Hayami M. Miyake A, et al. J Med Virol. 2004 Jul;73(3):368-77. doi: 10.1002/jmv.20100. J Med Virol. 2004. PMID: 15170630
Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques.
Xiao P, Zhao J, Patterson LJ, Brocca-Cofano E, Venzon D, Kozlowski PA, Hidajat R, Demberg T, Robert-Guroff M. Xiao P, et al. J Virol. 2010 Jul;84(14):7161-73. doi: 10.1128/JVI.00410-10. Epub 2010 May 5. J Virol. 2010. PMID: 20444898 Free PMC article.
86 results
Jump to page
Feedback